241 related articles for article (PubMed ID: 32259641)
21. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
22. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
[TBL] [Abstract][Full Text] [Related]
23. A new genome-driven integrated classification of breast cancer and its implications.
Dawson SJ; Rueda OM; Aparicio S; Caldas C
EMBO J; 2013 Mar; 32(5):617-28. PubMed ID: 23395906
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
[TBL] [Abstract][Full Text] [Related]
25. Proteomic classification of breast cancer.
Kamel D; Brady B; Tabchy A; Mills GB; Hennessy B
Curr Drug Targets; 2012 Nov; 13(12):1495-509. PubMed ID: 22974393
[TBL] [Abstract][Full Text] [Related]
26. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
27. [Hopes and pitfalls of the molecular classification of breast cancer].
Ryška A; Hovorková E; Sobande F; Rozkoš T; Laco J; Hornychová H
Cesk Patol; 2015; 51(1):26-32. PubMed ID: 25671359
[TBL] [Abstract][Full Text] [Related]
28. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
29. Molecular biology of breast cancer.
Martín M
Clin Transl Oncol; 2006 Jan; 8(1):7-14. PubMed ID: 16632434
[TBL] [Abstract][Full Text] [Related]
30. Decoding the usefulness of non-coding RNAs as breast cancer markers.
Amorim M; Salta S; Henrique R; Jerónimo C
J Transl Med; 2016 Sep; 14():265. PubMed ID: 27629831
[TBL] [Abstract][Full Text] [Related]
31. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
32. The subtype-specific molecular function of SPDEF in breast cancer and insights into prognostic significance.
Ye T; Li J; Feng J; Guo J; Wan X; Xie D; Liu J
J Cell Mol Med; 2021 Aug; 25(15):7307-7320. PubMed ID: 34191390
[TBL] [Abstract][Full Text] [Related]
33. Advances in the Molecular Taxonomy of Breast Cancer.
Guido LP; Gomez-Fernandez C
Arch Med Res; 2020 Nov; 51(8):777-783. PubMed ID: 32839004
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of gene-expression signatures in early stage breast cancer.
Kwa M; Makris A; Esteva FJ
Nat Rev Clin Oncol; 2017 Oct; 14(10):595-610. PubMed ID: 28561071
[TBL] [Abstract][Full Text] [Related]
35. Insight into the heterogeneity of breast cancer through next-generation sequencing.
Russnes HG; Navin N; Hicks J; Borresen-Dale AL
J Clin Invest; 2011 Oct; 121(10):3810-8. PubMed ID: 21965338
[TBL] [Abstract][Full Text] [Related]
36. Invited review-next-generation sequencing: a modern tool in cytopathology.
Roy-Chowdhuri S; Pisapia P; Salto-Tellez M; Savic S; Nacchio M; de Biase D; Tallini G; Troncone G; Schmitt F
Virchows Arch; 2019 Jul; 475(1):3-11. PubMed ID: 30877381
[TBL] [Abstract][Full Text] [Related]
37. Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer.
Marchio C; Balmativola D; Castiglione R; Annaratone L; Sapino A
Curr Drug Targets; 2017; 18(1):4-12. PubMed ID: 25654739
[TBL] [Abstract][Full Text] [Related]
38. Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions.
Zhang X; Yang H; Zhang R
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31387972
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers for precision medicine in bladder cancer.
Kojima T; Kawai K; Miyazaki J; Nishiyama H
Int J Clin Oncol; 2017 Apr; 22(2):207-213. PubMed ID: 27896485
[TBL] [Abstract][Full Text] [Related]
40. Precision medicine in breast cancer: From clinical trials to clinical practice.
Crimini E; Repetto M; Aftimos P; Botticelli A; Marchetti P; Curigliano G
Cancer Treat Rev; 2021 Jul; 98():102223. PubMed ID: 34049187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
